Life Sciences/Biotech Archives

Coronavirus: Amazon Suspends All Warehouse Shipments Except Medical Supplies, High-Demand Products

SEATTLE - Amazon has temporarily suspended the shipment of all items from independent merchants to its warehouses that are not medical supplies or “high-demand” products. This temporary suspension will go through 5 April as the e-commerce giant prioritises products relating to combating the growing coronavirus pandemic. “We are temporarily prioritising household staples, medical supplies and other high-demand

By Mike Brennan|2020-03-17T18:28:35-04:00March 17th, 2020|Featured, Life Sciences, Life Sciences/Biotech|

Study: 1 in 6 American Workers Could Be Negatively Impacted By Social Distancing

Study: 1 in 6 American Workers Could Be Negatively Impacted By Social Distancing

MUNCIE, Indiana – About 1 in 6 workers, or about 17 percent of U.S. employees, could be negatively impacted if social distancing becomes the norm as the nation attempts to contain COVID-19, says a new Ball State University report. “Occupational Exposure to Social Distancing: A Preliminary Analysis Using O*NET Data,” an analysis by Ball State’s

By Mike Brennan|2020-03-18T07:41:42-04:00March 16th, 2020|Life Sciences, Life Sciences/Biotech|

XLerateHealth Partners With U-M to Bring Biomedical Commercialization Program to Flint

FLINT - XLerateHealth, a Louisville, KY-based healthcare startup accelerator, has partnered with the University of Michigan to bring its Fast Forward Medical Innovation’s fastPACE biomedical entrepreneur program to XLH Flint. FFMI fastPACE is a four-week biomedical innovation and commercialization project-based course designed for life science innovators with an early stage project. More than 250 project

By Staff Writer|2020-01-20T09:33:23-05:00January 19th, 2020|Entrepreneur, Entrepreneurs, Life Sciences, Life Sciences/Biotech, STEM|

Flint’s Diplomat Specialty Pharmacy To Be Purchased By OptumRx

FLINT—Diplomat Specialty Pharmacy, a provider of specialty pharmacy and infusion services, will be purchased by Eden Prairie, Minn.-based OptumRx, the pharmacy care business of Optum, a unit of the health insurance giant United Health Group, for $4 a share in cash and assumption of outstanding debt, valuing the company at about $300 million. Diplomat stock

By Matt Roush|2019-12-15T16:02:15-05:00December 15th, 2019|Life Sciences, Life Sciences/Biotech, New Products / Contracts, Software, STEM|

Kraig scales up breeding silkworms for super-strong ‘spider silk’

ANN ARBOR–Kraig Biocraft Laboratories has completed the hatching of the second generation of its genetically engineered silkworms as it expands production at its breeding grounds and silk production centers in Quang Nam province, Vietnam. Company officials said that its Vietnamese subsidiary, Prodigy Textiles, would use the cocoons produced in this breeding cycle to begin its

By Matt Roush|2019-12-08T14:35:30-05:00December 8th, 2019|Life Sciences, Life Sciences/Biotech, New Products / Contracts|

New Genetic Research Software From Genomenon

New Genetic Research Software From Genomenon

ANN ARBOR—The Ann Arbor-based genetic research software developer Genomenon Inc. announced the release of version 2.0 of its Mastermind software. The genomic search engine now includes the ability to search the entirety of the genomic literature by phenotypes (symptoms). This new functionality will further accelerate diagnosis of patients with genetic and rare diseases. Patients, particularly those with

By Matt Roush|2019-11-14T11:11:10-05:00November 10th, 2019|ESD, Life Sciences, Life Sciences/Biotech|

TrialAssure Releases Anonymize DS To Automate Clinical Trail Data

CANTON - TrialAssure – a software company focused on developing clinical trial transparency tools – has released Anonymize DS, the all-new software-as-a-service application that uses automation to anonymize sponsor’s clinical trial data. “As one of the first groups to automate the anonymization of datasets, our developers heard first-hand feedback from industry users during the limited

By Mike Brennan|2019-09-29T20:08:58-04:00September 29th, 2019|As-A-Service, Life Sciences, Life Sciences/Biotech|

Henry Ford e-Home Care Cuts Hospital Readmissions

DETROIT—Henry Ford e-Home Care has announced a significant reduction in hospital readmissions for patients receiving telehealth care via Henry Ford’s e-Home Care program. Achieving monthly readmission rates as low as 7 percent, Henry Ford e-Home Care has reduced its average hospital readmission rate for the first six months of 2019 by 45 percent compared with

By Matt Roush|2019-09-22T12:59:07-04:00September 22nd, 2019|Life Sciences, Life Sciences/Biotech|

Genomenon Partners With Chinese To Sell Mastermind Genomic Search Engine

Genomenon Partners With Chinese To Sell Mastermind Genomic Search Engine

ANN ARBOR - Genomenon, Inc., and Shanghai Shanyi Biological Technology Co., Ltd have formed a partnership to provide Genomenon’s leading Mastermind Genomic Search Engine to clinical laboratory customers in China. Genomenon’s Mastermind is a genomic search engine wiith nearly 3,500 users in over 100 countries, becoming the search engine of choice when researching patient variants

By Staff Writer|2019-08-20T20:10:00-04:00August 20th, 2019|Life Sciences, Life Sciences/Biotech|

IDTechEx Research Finds 3D Bioprinted Organ Models Key To $1.9 Billion Market

IDTechEx Research Finds 3D Bioprinted Organ Models Key To $1.9 Billion Market

BOSTON - There is no doubt that 3D bioprinting is a technology of the future. Imagine being able to print a kidney or liver on demand. This is a stark contrast to the long wait for a donor organ today. Currently, the average wait time for a liver is 4 to 5 months and 2.5

By Staff Writer|2019-07-14T18:19:26-04:00July 14th, 2019|Life Sciences, Life Sciences/Biotech|